Mevion Receives Approval for First Compact, Integrated Proton Therapy System in China
Dec 18, 2024•7 months ago
Contract Type
partnership
Description
Mevion Medical Systems has received approval from the National Medical Products Administration (NMPA) of China for its MEVION S250i Proton Therapy System, marking the first time this advanced technology has been approved in China. This approval is a testament to the company's commitment to providing innovative and accessible cancer treatment solutions.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months